Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma--tissue immunoreactivity predicts aggressive clinical course.

Add item related to this paper

  • MiniManuscript ID
    2489
  • Pubmed ID
    16424893